Acrylamide exposure and pulmonary function reduction in general population: The mediating effect of systemic inflammation

Bin Wang,Xing Wang,Shijie Yang,Man Cheng,Yun Zhou,Min Zhou,Zi Ye,Weihong Qiu,Heng He,Xingzu Cen,Chunmei Zhu,Limin Cao,Ge Mu,Jixuan Ma,Dongming Wang,Lili Xiao,Jing Yuan,Weihong Chen

DOI: https://doi.org/10.1016/j.scitotenv.2021.146304

2021-07-01

Abstract:<p>Acrylamide exposure along with resultant potential adverse health effects have attracted global concern, and the World Health Organization calls for more and urgent studies on the health risks from acrylamide. However, the association and mechanism between acrylamide exposure and pulmonary dysfunction remain unclear. Our goals were to investigate the relationship of internal acrylamide exposure with lung function reduction, and the potential mediating role of systematic inflammation in that relationship. Our study was conducted within the Wuhan-Zhuhai cohort. Urinary biomarkers of acrylamide exposure (<em>N</em>-acetyl-S-(2-carbamoylethyl)-<span class="small-caps">l</span>-cysteine, AAMA; <em>N</em>-acetyl-S-(2-carbamoyl-2-hydroxyethyl)-<span class="small-caps">l</span>-cysteine, GAMA) and lung function were determined among 3271 general adults, of whom 2595 had test results of systemic inflammatory marker plasma C-reactive protein (CRP). We employed linear mixed models to assess the relations among urinary acrylamide metabolites, pulmonary function and plasma CRP, and PRODCLIN program to evaluate the mediating role of CRP. We observed that urinary acrylamide metabolites were inversely and dose-dependently related to lung function (<em>P</em> trend&lt;0.05). Each 1-unit increment in log-transformed level of AAMA, GAMA, or AAMA+GAMA (ΣUAAM) was significantly (<em>P</em> &lt; 0.05) related to a 59.9-, 64.2-, or 64.3-mL reduction in FVC, and a 53.9-, 59.7-, or 58.5-mL reduction in FEV₁, respectively. Such relationships were independent of smoking, and were significant in physically inactive rather than physically active participants. AAMA (β = 0.10), GAMA (β = 0.16) and ΣUAAM (β = 0.12) were significantly (<em>P</em> &lt; 0.05) related to increased CRP, which was significantly (<em>P</em> &lt; 0.05) related to reduced FVC (β = −55.3) and FEV₁ (β = −40.6). We further found that increased CRP significantly (<em>P</em> &lt; 0.05) mediated 6.34–11.1% of the urinary acrylamide metabolites-associated lung function reductions. For the first time, our findings suggested that exposure to acrylamide in daily life was related to reduced lung function and increased systemic inflammation in general population, and systemic inflammation further mediated acrylamide-associated lung function reduction, indicating a potential mechanistic role of systemic inflammation underlying pulmonary dysfunction from acrylamide exposure.</p>

environmental sciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the relationship between acrylamide exposure and the decline of lung function, as well as the potential mediating role of systemic inflammation in this relationship. Specifically, the research aims to:

1. **Investigate the relationship between internal acrylamide exposure and the decline of lung function**: Analyze the association between the levels of acrylamide metabolites in urine (such as N - acetyl - S-(2 - carboxyethyl)-L - cysteine (AAMA) and N - acetyl - S-(2 - carboxy - 2 - hydroxyethyl)-L - cysteine (GAMA)) and lung function indicators (such as forced vital capacity (FVC) and forced expiratory volume in one second (FEV1)).

2. **Explore the mediating role of systemic inflammation in the relationship between acrylamide exposure and the decline of lung function**: Detect the level of plasma C - reactive protein (CRP) to evaluate whether systemic inflammation plays a mediating role in the decline of lung function caused by acrylamide exposure.

The research background points out that acrylamide is a chemical substance widely existing in daily foods, and its potential health risks have attracted global attention. Although previous studies have shown that acrylamide exposure may be related to a variety of health problems, its impact on the respiratory system and its mechanism are still unclear. Therefore, this study fills the knowledge gap in this field, provides empirical evidence of the relationship between acrylamide exposure and the decline of lung function, and reveals the potential mechanism of systemic inflammation in this process.